000 | 02439cam a22004338i 4500 | ||
---|---|---|---|
999 |
_c459 _d459 |
||
001 | 18207236 | ||
003 | OSt | ||
005 | 20181108132540.0 | ||
008 | 140630s2014 enk b 001 0 eng | ||
010 | _a 2014025599 | ||
020 | _a9781119979661 (cloth) | ||
035 | _a(DNLM)101635803 | ||
040 |
_aDNLM/DLC _erda _cINAYA MEDICAL COLLEGE |
||
041 | _aENG | ||
042 | _apcc | ||
050 | 0 | 0 | _aR853.C55 |
060 | 1 | 0 | _aQV 771 |
082 | 0 | 0 |
_a615.50724 GAS _223 |
100 |
_9378 _aGould,A. Lawrence |
||
245 | 0 | 0 | _aStatistical methods for evaluating safety in medical product development |
263 | _a1501 | ||
264 | 1 |
_aChichester, West Sussex, United Kingdom ; _aHoboken : _bJohn Wiley & Sons Inc., _c2014. |
|
300 |
_ap. ; _ccm. |
||
336 |
_atext _2rdacontent |
||
337 |
_aunmediated _2rdamedia |
||
338 |
_avolume _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aSafety graphics / A. Lawrence Gould -- QSAR modeling : prediction of biological activity from chemical structure / Andy Liaw and Vladimir Svetnik -- Ethical and practical issues in phase I trials in healthy volunteers / Stephen Senn -- Phase I trials / A. Lawrence Gould -- Summarizing adverse event risk / A. Lawrence Gould -- Statistical analysis of recurrent adverse events / Liqun Diao, Richard J. Cook, and Ker-Ai Lee -- Cardiovascular toxicity, especially QT/QTc prolongation / Arne Ring and Robert Schall -- Hepatic toxicity / Donald C. Trost -- Neurotoxicity / A. Lawrence Gould -- Safety monitoring / Jay Herson -- Sequential testing for safety evaluation / Jie Chen -- Evaluation of post-marketing safety using spontaneous reporting databases / Ismail Ahmed, Bernard Begaud, and Pascale Tubert-Bitter / Pharmacovigilance using observational/longitudinal databases and web-based information / A. Lawrence Gould. | |
650 | 1 | 2 |
_aDrug Evaluation _xmethods. |
650 | 2 | 2 | _aClinical Trials as Topic. |
650 | 2 | 2 | _aModels, Statistical. |
650 | 2 | 2 | _aPharmacovigilance. |
650 | 2 | 2 |
_aSafety Management _xmethods. |
650 | 2 | 2 |
_aTechnology, Pharmaceutical _xstandards. |
700 | 1 |
_aGould, Lawrence _q(A. Lawrence), _eeditor. |
|
776 | 0 | 8 |
_iOnline version: _tStatistical methods for evaluating safety in medical product development _dChichester, West Sussex, United Kingdom ; Hoboken : John Wiley & Sons Inc., 2014 _z9781118763094 _w(DLC) 2014026252 |
906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
942 |
_2ddc _cBK |